The US financial crisis has taken its toll on Orchid Chemicals & Pharmaceuticals. The active pharmaceutical ingredients (API) manufacturer saw its stock price decline by about 44% since the start of the week after Bear Stearns decided to sell a...
If you use an RSS reader, you can subscribe to a feed of all future entries tagged 'Bear Stearns'. [What is this?]